logo-loader

Morning Report: Smiths Group halts planned demerger of medical arm

Headlines from the Proactive UK newsroom.

Smiths Group (LON:SMIN) has halted the planned demerger of its medical arm due to the coronavirus crisis. Smiths Medical needs to concentrate on the delivery of ventilators and other critical care devices, though the intention remains to separate once the crisis passes.

American Airlines is to ask the US government for US$12bn to help it keep flying through all potential future scenarios. Several UK airlines are expected to ask for a bailout from the government here this week.

Domino's Pizza (LON:DOM) has appointed former Costa Coffee boss Dominic Paul to become its chief executive from April.  Current Chief David Wild will retire on 1 May.

Verona Pharma (LON:VRP) has reported encouraging signs of efficacy in a phase II trial of a single dose of its COPD treatment ensifentrine. Statistically significant improvements in lung function were observed in the 40 patients.

88 Energy’s (LON:88E) Charlie-1 well in Alaska encountered ‘shows’ and ‘elevated log responses’ over several horizons on its way to target depth. The logging data to date is “largely consistent” the company says with that recorded at the Malguk-1 well drilled by BP in 1991.

And Synairgen (LON:SNG) has started dosing patients in its trial of an interferon-beta treatment in coronavirus patients. The first patient was at the University Hospital Southampton with a further six trial sites expected to start dosing shortly.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

OKYO Pharma appoints top Beverly Hills surgeon to lead its Scientific...

Dr James Khodabakhsh MD speaks to Proactive's Andrew Scott following his appointment as chair of OKYO Pharma's (LON:OKYO) Scientific Advisory Board. He'll be tasked with bringing together a small group of leaders to review and inform the company's plans to progress its lead product candidate...

3 hours, 23 minutes ago

2 min read